Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-related Macular Degeneration (ARMD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07557121
What this trial is testing

Safety and Efficacy of AIV007 Periocular Injection in Patients With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular (Wet) Age-Related Macular Degeneration
AiViva BioPharma, Inc. 35
Not applicableStudy completedNCT02941263
What this trial is testing

Natural History of Geographic Atrophy Associated With Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
National Eye Institute (NEI) 20
Large-scale testing (Phase 3)UnknownNCT05480293
What this trial is testing

This Study Will Compare the Efficacy and Safety of SCT510A Administered by Intravitreal Injection (IVT) With Ranibizumab in Patients With wAMD

Who this might be right for
Wet Age-related Macular Degeneration
Sinocelltech Ltd. 446
Testing effectiveness (Phase 2)UnknownNCT03710863
What this trial is testing

Safety and Tolerability of Oral CM082 in Patients With wAMD

Who this might be right for
Age-Related Macular Degeneration
AnewPharma 64
Large-scale testing (Phase 3)Study completedNCT02818998
What this trial is testing

Efficacy and Safety of Three Different Aflibercept Regimens in Subjects With Diabetic Macular Edema (DME)

Who this might be right for
Macular Edema
Bayer 463
Not applicableStudy completedNCT01316198
What this trial is testing

Effects of Xanthophylls on Optical Density

Who this might be right for
Age-Related Macular Degeneration
University of Jena 20
Not applicableLooking for participantsNCT06694272
What this trial is testing

Functional and Anatomical Visual Investigations in Patients With Early Forms of Age-related Macular Degeneration

Who this might be right for
Age Related Macular Degeneration
Fondation Ophtalmologique Adolphe de Rothschild 120
Not applicableEnded earlyNCT02995746
What this trial is testing

Intravitreal Dexamethasone Implant for Persistent Macular Thickening and Edema After Vitrectomy for Epiretinal Membrane

Who this might be right for
Macular EdemaEpiretinal MembraneVitrectomy
Wills Eye 3
Not applicableLooking for participantsNCT07178639
What this trial is testing

Comparing Efficacy of Bromfenac 0.09%, Nepafenac 0.3% and Diclofenac 0.1% in Patients After Cataract Surgery

Who this might be right for
Macular OedemaCataract SurgeryNSAID (Non-Steroidal Anti-Inflammatory Drug)
Nemocnice Kolín 150
Large-scale testing (Phase 3)Study completedNCT04976777
What this trial is testing

Evaluate an Updated Dexamethasone Intravitreal (Into the Eye) Applicator in Adult Participants With Macular Edema Due to Diseases of the Retina

Who this might be right for
Macular Edema
AbbVie 54
Testing effectiveness (Phase 2)Study completedNCT01485588
What this trial is testing

Safety and Tolerability Study for Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Iconic Therapeutics, Inc. 18
Testing effectiveness (Phase 2)Study completedNCT01376362
What this trial is testing

Topical Interferon Gamma for Macular Edema Secondary to Uveitis

Who this might be right for
Anterior UveitisUveitis
National Eye Institute (NEI) 5
Post-approval studies (Phase 4)Study completedNCT00751361
What this trial is testing

Dry Age-Related Macular Degeneration (AMD) Treatment With Rheopheresis Trial

Who this might be right for
Dry Age Related Macular Degeneration
Apheresis Research Institute 52
Testing effectiveness (Phase 2)Study completedNCT05141994
What this trial is testing

Clinical Study on the Efficacy and Safety of BAT5906 Injection

Who this might be right for
Wet Age-related Macular Degeneration
Bio-Thera Solutions 48
Testing effectiveness (Phase 2)Ended earlyNCT02418754
What this trial is testing

Study of Intravitreal REGN2176-3 in Participants With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)

Who this might be right for
Neovascular Age-Related Macular Degeneration
Regeneron Pharmaceuticals 505
Testing effectiveness (Phase 2)Study completedNCT00288561
What this trial is testing

Study of Ranibizumab Administered in Conjunction With Photodynamic Therapy With Verteporfin in Patients With Subfoveal Choroidal Neovascularization and Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration (ARMD)
Novartis
Testing effectiveness (Phase 2)Study completedNCT02515942
What this trial is testing

CLG561 Proof-of-Concept Study as a Monotherapy and in Combination With LFG316 in Subjects With Geographic Atrophy (GA)

Who this might be right for
Geographic Atrophy
Alcon Research 114
Not applicableStudy completedNCT02540369
What this trial is testing

To Describe the Use of Intravitreal Aflibercept and to Describe Follow-up as Well as Treatment Patterns in Patients With Wet Age-related Macular Degeneration (wAMD) or Diabetic Macular Edema (DME) in Routine Clinical Practice in Canada.

Who this might be right for
Wet Macular Degeneration
Bayer 2,150
Testing effectiveness (Phase 2)Ended earlyNCT04684394
What this trial is testing

A Multiple Dose Study of Repeat Intravitreal Injections of GEM103 in Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular DegenerationRetinal DiseaseRetinal Degeneration+1 more
Gemini Therapeutics, Inc. 50
Large-scale testing (Phase 3)Not Yet RecruitingNCT07489586
What this trial is testing

A Clinical Study of QL1207H Injection Versus Aflibercept for Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)
Qilu Pharmaceutical Co., Ltd. 356
Next Page